Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients

Authors

Keywords

HDL, Niacin, Fenofibrate, Preβ1-HDL, PON1, PON3, CETP, LCAT, PAF-AH, Type 2 diabetes, HDL particle size, Nuclear magnetic resonance

Journal

Volume 238, Issue 2, Pages 213-219

Publisher

Elsevier BV

Online

2014-12-10

DOI

10.1016/j.atherosclerosis.2014.12.006

Contact the author

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started